Skip to main content

Table 1 Summary of Clinical Commissioning Group gluten-free prescribing policies in 2017

From: Breaking bread: examining the impact of policy changes in access to state-funded provisions of gluten-free foods in England

Policy type

Frequency (%)

Partial restrictions on products and/or unitsa

70 (34%)

No ban

61 (29%)

Complete ban

46 (22%)

Policy under review

18 (9%)

Complete ban (with age-related exceptions)b

12 (6%)

  1. aPrescribing was limited to a lower number of monthly units or a restricted set of products which was largely dependent on the individual Clinical Commissioning Group
  2. bGluten-free products still prescribed for children/adolescents under the age of 18 or 19, and in some cases pregnant women